Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Bio (TELA) over the last 7 years, with Q3 2025 value amounting to -$0.19.

  • Bio's EPS (Weighted Average and Diluted) rose 5476.19% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.83, marking a year-over-year increase of 5088.76%. This contributed to the annual value of -$1.33 for FY2024, which is 3497.43% up from last year.
  • Per Bio's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.19 for Q3 2025, which was up 5476.19% from -$0.22 recorded in Q2 2025.
  • Bio's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.19 during Q3 2025, with a 5-year trough of -$0.88 in Q2 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.49, with a median of -$0.51 in 2024.
  • Per our database at Business Quant, Bio's EPS (Weighted Average and Diluted) crashed by 5438.6% in 2022 and then skyrocketed by 6349.21% in 2024.
  • Over the past 5 years, Bio's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.59 in 2021, then rose by 18.64% to -$0.48 in 2022, then fell by 10.42% to -$0.53 in 2023, then surged by 38.14% to -$0.33 in 2024, then skyrocketed by 42.04% to -$0.19 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.19 in Q3 2025, compared to -$0.22 in Q2 2025 and -$0.25 in Q1 2025.